Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters

Database
Language
Journal subject
Affiliation country
Publication year range
1.
J Am Soc Nephrol ; 25(11): 2499-510, 2014 Nov.
Article in English | MEDLINE | ID: mdl-24722447

ABSTRACT

Nuclear hormone receptors of the NR4A subgroup have been implicated in cancer, atherosclerosis, and metabolic disease. However, little is known about the role of these receptors in kidney health or disease. Nr4a1-deficient rats (Nr4a1(-/-)) developed on a genetic background susceptible to kidney injury (fawn-hooded hypertensive rat [FHH]) were evaluated for BP, proteinuria, renal function, and metabolic parameters from 4 to 24 weeks-of-age. By week 24, Nr4a1(-/-) rats exhibited significantly higher proteinuria (approximately 4-fold) and decreased GFR compared with FHH controls. The severity of tubular atrophy, tubular casts, and interstitial fibrosis increased significantly in Nr4a1(-/-) rats and was accompanied by a large increase in immune cell infiltration, predominantly macrophages and to a lesser extent T cells and B cells. Global transcriptome and network analyses at weeks 8, 16, and 24 identified several proinflammatory genes and pathways differentially regulated between strains. Bone marrow crosstransplantation studies demonstrated that kidney injury in Nr4a1(-/-) rats was almost completely rescued by bone marrow transplanted from FHH controls. In vitro, macrophages isolated from Nr4a1(-/-) rats demonstrated increased immune activation compared with FHH-derived macrophages. In summary, the loss of Nr4a1 in immune cells appears to cause the increased kidney injury and reduced renal function observed in the Nr4a1(-/-) model.


Subject(s)
Macrophages/immunology , Nuclear Receptor Subfamily 4, Group A, Member 1/genetics , Nuclear Receptor Subfamily 4, Group A, Member 1/immunology , Renal Insufficiency, Chronic/genetics , Renal Insufficiency, Chronic/immunology , Animals , Bone Marrow Transplantation , Cells, Cultured , Disease Models, Animal , Genetic Linkage , Genetic Predisposition to Disease , Kidney Glomerulus/immunology , Kidney Glomerulus/metabolism , Kidney Tubules/immunology , Kidney Tubules/metabolism , Macrophages/cytology , Male , Proteinuria/genetics , Proteinuria/immunology , Proteinuria/metabolism , Rats, Inbred Strains , Rats, Mutant Strains , Renal Insufficiency, Chronic/metabolism , Transcriptome
2.
J Am Soc Nephrol ; 16(4): 950-8, 2005 Apr.
Article in English | MEDLINE | ID: mdl-15728782

ABSTRACT

Heme oxygenase (HO) induction has been demonstrated to be beneficial in limiting the extent of cellular damage after ischemia-induced acute renal failure (ARF). Because increased HO activity is associated with the production of carbon monoxide (CO) as well as the potent antioxidant bilirubin, it is unclear which of the two is of greater importance in the protective effects of HO induction. The purpose of this study was to determine the protective role of CO alone in ischemia-induced ARF. Bilateral clamping of the renal pedicle for 40 min was associated with a ninefold increase in the levels of plasma creatinine 24 h after reperfusion as compared with normal plasma creatinine levels; however, administration of CO donor compounds tricarbonyldichlororuthenium(II) dimer, ([Ru(CO)(3)Cl(2)](2), 10 mg/kg) or tricarbonylchloro(glycinato)ruthenium(II) ([Ru(CO)(3)Cl(glycinate)], (CORM-3) 1 h before the onset of ischemia significantly decreased the levels of plasma creatinine 24 h after reperfusion as compared with vehicle-treated mice. Surprising, treatment with the CO donors was associated with an increase in HO activity 24 h after ischemia. For determining whether the protective effects of the CO donors were due to CO or HO-1 induction, experiments were performed in which HO was inhibited before administration of the CO donors. Pretreatment with the HO inhibitor had no effect on the level of plasma creatinine 24 h after reperfusion after treatment with the CO donor compounds. These results suggest that CO itself may be protective and limit renal damage in ischemia induced ARF.


Subject(s)
Acute Kidney Injury/pathology , Carbon Monoxide/metabolism , Cytoprotection , Ischemia/complications , Kidney/blood supply , Organometallic Compounds/pharmacology , Acute Kidney Injury/etiology , Acute Kidney Injury/metabolism , Animals , Creatinine/blood , Enzyme Inhibitors/pharmacology , Heme Oxygenase (Decyclizing)/antagonists & inhibitors , Heme Oxygenase (Decyclizing)/metabolism , Heme Oxygenase-1 , Ischemia/blood , Ischemia/enzymology , Kidney/drug effects , Kidney/metabolism , Kidney/pathology , Kidney Tubules/drug effects , Kidney Tubules/pathology , Membrane Proteins , Mice , Mice, Inbred C57BL , Time Factors , Zinc/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL